Newlink Genetics reported -7924000 in EBIT for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebit Change
Agenus AGEN:US $ -44972000 8.98M
Bristol Myers Squibb BMY:US $ 3197M 9M
Capricor Therapeutics CAPR:US -5821750 209.78K
Celldex Therapeutics CLDX:US $ -21396000 1.86M
Eli Lilly And LLY:US $ 1650.5M 919.4M
Idera Pharmaceuticals IDRA:US $ -5365000 1.18M
Merk MRK:US $ 5711M 652M
Nektar Therapeutics NKTR:US $ -47713000 67.37M
Newlink Genetics NLNK:US -7924000 193K
Pfizer PFE:US $ 12099M 2104M
Prothena PRTA:US -43209000 5.26M
Sarepta Therapeutics SRPT:US $ -211132000 124.25M
Vascular Biogenics VBLT:US -9614000 950K
YTE INCY:US $ 260.29M 132.62M